- Home
- KURA vs ALEX Comparison
KURA vs ALEX Comparison
Compare KURA & ALEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- ALEX
- Stock Information
- Founded
- KURA 2014
- ALEX 1870
- Country
- KURA United States
- ALEX United States
- Employees
- KURA N/A
- ALEX N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- ALEX Real Estate Investment Trusts
- Sector
- KURA Health Care
- ALEX Real Estate
- Exchange
- KURA Nasdaq
- ALEX Nasdaq
- Market Cap
- KURA 1.5B
- ALEX 1.4B
- IPO Year
- KURA N/A
- ALEX N/A
- Fundamental
- Price
- KURA $19.29
- ALEX $19.13
- Analyst Decision
- KURA Strong Buy
- ALEX Strong Buy
- Analyst Count
- KURA 6
- ALEX 4
- Target Price
- KURA $30.60
- ALEX $21.33
- AVG Volume (30 Days)
- KURA 434.9K
- ALEX 331.7K
- Earning Date
- KURA 10-31-2024
- ALEX 10-31-2024
- Dividend Yield
- KURA N/A
- ALEX 4.66%
- EPS Growth
- KURA N/A
- ALEX N/A
- EPS
- KURA N/A
- ALEX 0.55
- Revenue
- KURA N/A
- ALEX $220,308,000.00
- Revenue This Year
- KURA N/A
- ALEX N/A
- Revenue Next Year
- KURA N/A
- ALEX $2.31
- P/E Ratio
- KURA N/A
- ALEX $26.56
- Revenue Growth
- KURA N/A
- ALEX N/A
- 52 Week Low
- KURA $7.41
- ALEX $15.53
- 52 Week High
- KURA $24.17
- ALEX $20.30
- Technical
- Relative Strength Index (RSI)
- KURA 42.25
- ALEX 50.60
- Support Level
- KURA $19.93
- ALEX $19.51
- Resistance Level
- KURA $21.57
- ALEX $19.79
- Average True Range (ATR)
- KURA 0.74
- ALEX 0.31
- MACD
- KURA -0.01
- ALEX -0.06
- Stochastic Oscillator
- KURA 6.56
- ALEX 40.00
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.
About ALEX Alexander & Baldwin Inc. REIT Holding Company
Alexander & Baldwin Inc operates in the real estate sector. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces and also urban ground leases in Hawaii, thereby accounting for majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.